找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte

[復(fù)制鏈接]
樓主: 指責
21#
發(fā)表于 2025-3-25 05:03:52 | 只看該作者
22#
發(fā)表于 2025-3-25 08:41:54 | 只看該作者
23#
發(fā)表于 2025-3-25 11:44:58 | 只看該作者
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
24#
發(fā)表于 2025-3-25 17:22:12 | 只看該作者
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
25#
發(fā)表于 2025-3-25 22:26:03 | 只看該作者
26#
發(fā)表于 2025-3-26 00:57:08 | 只看該作者
27#
發(fā)表于 2025-3-26 04:37:57 | 只看該作者
28#
發(fā)表于 2025-3-26 08:42:03 | 只看該作者
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
29#
發(fā)表于 2025-3-26 13:37:23 | 只看該作者
30#
發(fā)表于 2025-3-26 18:28:43 | 只看該作者
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
庄河市| 盱眙县| 加查县| 延安市| 平江县| 定边县| 辽宁省| 五峰| 沈丘县| 多伦县| 且末县| 德钦县| 隆安县| 余姚市| 洛南县| 湘阴县| 河南省| 眉山市| 丰城市| 福贡县| 图木舒克市| 凤翔县| 阿城市| 鄂伦春自治旗| 栾川县| 白玉县| 新晃| 赞皇县| 新巴尔虎右旗| 墨竹工卡县| 乌鲁木齐市| 贡山| 金坛市| 洛扎县| 马尔康县| 河东区| 高淳县| 怀化市| 鄄城县| 平山县| 乌什县|